Relapse, re-infection and mixed infections in tuberculosis disease

Pathogens and Disease

Volumn 75, Issue 3, 2017, Pages

  McIvor, Amanda ^a   Koornhof, Hendrik ^b   Kana, Bavesh Davandra ^a,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Heteroresistance; Mixed infections; Re infection; Recurrent disease; Relapse; Tuberculosis

Indexed keywords

AFRICA; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CULTURE MEDIUM; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REINFECTION; RELAPSE; SHORT SURVEY; SPUTUM; TUBERCULOSIS; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; CLASSIFICATION; DRUG EFFECTS; GENETICS; MICROBIOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; COINFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 85020319236     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftx020     Document Type: Short Survey

References (108)

1. Andrews JR, Gandhi NR, Moodley P et al. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa. J Infect Dis 2008;198:1582-9
2. Baldeviano-Vidalon G, Quispe-Torres N, Bonilla-Asalde C et al. Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. Int J Tuberc Lung D 2005;9:1155-60
3. Bandera A, Gori A, Catozzi L et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 2001;39:2213-8
4. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. New Engl J Med 2003;349:1149-56
5. Bates JH, Stead WW, Rado TA. Phage type of tubercle bacilli isolated from patients with two or more sites of organ involvement. Am Rev Respir Dis 1976;114:353-8
6. Bauer J, Andersen AB, Kremer K et al. Usefulness of spoligotyping to discriminate IS6110 low-copy-number Mycobacterium tuberculosis complex strains cultured in Denmark. J Clin Microbiol 1999;37:2602-6
7. Braden CR,Morlock GP,Woodley CL et al. Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis 2001;33:e42-7
8. Bryant JM, Harris SR, Parkhill J et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med 2013;1:786-92
9. Caminero JA, Pena MJ, Campos-Herrero MI et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care 2001;163: 717-20
10. Cave M, Eisenach KD, Templeton G et al. Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol 1994;32:262-6
11. Charalambous S, Grant AD, Moloi V et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung D 2008;12:942-8
12. Chaves F, Dronda F, Alonso-Sanz M et al. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates. AIDS 1999;13:615-20
13. Chengalroyen MD, Beukes GM, Gordhan BG et al. Detection and quantification of differentially culturable tubercle bacteria in sputum from tuberculosis patients. Am J Respir Crit Care 2016;194:1532-40
14. Cohen T, van Helden PD, Wilson D et al. Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev 2012;25:708-19
15. Cohen T, Wilson D, Wallengren K et al. Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. J Clin Microbiol 2011;49:385-8
16. Cox HS, Kalon S, Allamuratova S et al. Multidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failures. PLoS One 2007;2:e1126
17. Crampin AC, Glynn JR, Fine PE. What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung D 2009;13:153-64
18. Dartois V, Saito K,Warrier T et al. New evidence for the complexity of the population structure of Mycobacterium tuberculosis increases the diagnostic and biologic challenges. Am J Respir Crit Care 2016;194:1448-51
19. Das S, Narayanan S, Hari L et al. Simultaneous infection with multiple strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung D 2004;8:267-70
20. de Boer AS, Kremer K, Borgdorff MW et al. Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as lowintensity bands. J Clin Microbiol 2000;38:4478-84
21. de Viedma DG, Marín M, Serrano MJR et al. Polyclonal and compartmentalized infection by Mycobacterium tuberculosis in patients with both respiratory and extrarespiratory involvement. J Infect Dis 2003;187:695-9
22. de Viedma DG, Rodriguez NA, Andrés S et al. Characterization of clonal complexity in tuberculosis by mycobacterial interspersed repetitive unit-variable-number tandem repeat typing. J Clin Microbiol 2005;43:5660-4
23. Dheda K, Limberis J, Pietersen E et al. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir Med 2017, in press. http://dx.doi.org/10.1016/52212-2600(16)30433-7
24. Dheda K, Shean K, Zumla A et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 2010;375:1798-807
25. Dickman KR, Nabyonga L, Kateete DP et al. Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda. BMC Infect Dis 2010;10:349
26. du Plessis DG, Warren R, Richardson M et al. Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting. Tuberculosis 2001;81: 211-20
27. Fang R, Li X, Li J et al. Mixed infections of Mycobacterium tuberculosis in tuberculosis patients in Shanghai, China. Tuberculosis 2008;88:469-73
28. Fine PE. Bacille Calmette-Guerin vaccines: a rough guide. Clin Infect Dis 1995;20:11-4
29. Ford C, Yusim K, Ioerger T et al. Mycobacterium tuberculosis heterogeneity revealed through whole genome sequencing. Tuberculosis 2012;92:194-201
30. Gan M, Liu Q, Yang C et al. Deep whole-genome sequencing to detect mixed infection of Mycobacterium tuberculosis. PLoS One 2016;11:e0159029
31. Garton NJ, Waddell SJ, Sherratt AL et al. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med 2008;5:e75
32. Ghandi N, Moll A, Sturm A et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80
33. Godfrey-Faussett P, Githui W, Batchelor B et al. Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection. Tuber Lung Dis 1994;75:199-202
34. Godfrey-Faussett P, Sonnenberg P, Shearer SC et al. Tuberculosis control and molecular epidemiology in a South African goldmining community. Lancet 2000;356:1066-71
35. Guerra-Assunção JA, Houben RM, Crampin AC et al. Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up. J Infect Dis 2015;211:1154-63
36. Gutacker MM, Mathema B, Soini H et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from4 geographic sites. J Infect Dis 2006;193:121-8
37. Hanekom M, Streicher E, Van de Berg D et al. Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent. PLoS One 2013;8:e70178
38. Hingley-Wilson SM, Casey R, Connell D et al. Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg Infect Dis 2013;19:1138-41
39. Huang H-Y, Tsai Y-S, Lee J-J et al. Mixed infection with Beijing and non-Beijing strains and drug resistance pattern of Mycobacterium tuberculosis. J Clin Microbiol 2010; 48:4474-80
40. HuyenMN, Kremer K, Lan NT et al. Mixed tuberculosis infections in rural South Vietnam. J Clin Microbiol 2012;50:1586-92
41. Jones-L ópez EC, Namugga O, Mumbowa F et al. Cough aerosols of Mycobacterium tuberculosis predict new infection. A household contact study. Am J Respir Crit Care 2013;187:1007-15
42. Kamakoli M, Sadegh H, Farmanfarmaei M et al. Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients. Sci Rep 2017;7:41410, DOI: 10.1038/srep41410
43. Kamerbeek J, Schouls L, Kolk A et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997;35:907-14
44. Kana BD, Karakousis P, Parish T et al. Future target-based drug discovery for tuberculosis? Tuberculosis 2014;94: 551-6
45. Kaplan G, Post FA, Moreira AL et al. Mycobacterium tuberculosis growth at the cavity surface: amicroenvironment with failed immunity. Infect Immun 2003;71:7099-108
46. Kay GL, Sergeant MJ, Zhou Z et al. Eighteenth-century genomes show that mixed infections were common at time of peak tuberculosis in Europe. Nat Commun 2015;6:6717, DOI: 10.1038/ncomms7717
47. Kell DB, Young M. Bacterial dormancy and culturability: the role of autocrine growth factors: commentary. Curr Opin Microbiol 2000;3:238-43
48. Klopper M, Warren RM, Hayes C et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis 2013;19:449-55
49. Kremer K, van Soolingen D, Frothingham R et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999;37:2607-18
50. Kritzinger FE, den Boon S, Verver S et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health 2009;14:136-42
51. Kruuner A, Pehme L, Ghebremichael S et al. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2002;35:146-55
52. Lambert ML, Hasker E, Van Deun A et al. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003;3:282-7
53. Lan NT, Lien HT, Tung le B et al. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003;9:1633-5
54. Lieberman TD, Wilson D, Misra R et al. Genomic diversity in autopsy samples reveals within-host dissemination of HIVassociated Mycobacterium tuberculosis. Nat Med 2016;22:1470-6
55. Lopez B, Aguilar D, OrozcoHet al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003;133:30-7
56. Loraine J, Pu F, Turapov O et al. Development of an in vitro assay for detection of drug-induced resuscitation-promotingfactor-dependent mycobacteria. Antimicrob Agents Ch 2016;60:6227-33
57. Luzze H, Johnson DF, Dickman K et al. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung D 2013;17: 361-7
58. Mallard K, McNerney R, Crampin AC et al. Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga district, Malawi. J Clin Microbiol 2010;48:4512-8
59. Mankiewicz E, Liivak M. Phage types of Mycobacterium tuberculosis in cultures isolated from Eskimo patients. Am Rev Respir Dis 1975;111:307-12
60. Martín A, Herranz M, Serrano MJR et al. The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture. Tuberculosis 2010;90:201-7
61. Marx FM, Dunbar R, Enarson DA et al. The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis 2014;58:1676-83
62. Mathema B, Kurepina NE, Bifani PJ et al. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006;19:658-85
63. Middelkoop K, Bekker LG, Mathema B et al. Factors affecting tuberculosis strain success over 10 years in a high TB-and HIVburdened community. Int J Epidemiol 2014;43:1114-22
64. Middelkoop K, Bekker LG, Shashkina E et al. Retreatment tuberculosis in a South African community: the role of reinfection, HIV and antiretroviral treatment. Int J Tuberc Lung D 2012;16:1510-6
65. Middelkoop K, Mathema B, Myer L et al. Transmission of tuberculosis in a South African communitywith a high prevalence of HIV infection. J Infect Dis 2015;211:53-61
66. Mokrousov I, Valcheva V, Sovhozova N et al. Penitentiary population of Mycobacterium tuberculosis in Kyrgyzstan: exceptionally high prevalence of the Beijing genotype and its Russiaspecific subtype. Infect Genet Evol 2009;9:1400-5
67. Mukamolova GV, Turapov O, Malkin J et al. Resuscitationpromoting factors reveal an occult population of tubercle bacilli in sputum. Am J Respir Crit Care 2010;181:174-80
68. Mulenga C, Shamputa IC, Mwakazanga D et al. Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia. BMC Infect Dis 2010;10:1
69. Mustafa S, Hasnain J, Hashmi J et al. Emergence of mixed infection of Beijing/non-Beijing strains among multi-drug resistant Mycobacterium tuberculosis in Pakistan. Biotech 2016;6:108
70. Muwonge A, Kankya C, Olea-Popelka F et al. Molecular investigation of multiple strain infections in patients with tuberculosis in Mubende district, Uganda. Infect Genet Evol 2013;17:16-22
71. Niemann S, Richter E, Rusch-Gerdes S et al. Double infection with a resistant and amultidrug-resistant strain of Mycobacterium tuberculosis. Emerg Infect Dis 2000;6:548-51
72. Pai M, Behr M, Dowdy D et al. Tuberculosis. Nat Rev Dis Primers 2016;2:16706
73. Pang Y, Zhou Y,Wang S et al. Prevalence and risk factors of mixed Mycobacterium tuberculosis complex infections in China. J Infect 2015;71:231-7
74. Peng Y, Yang C, Li X et al. Multiple samples improve the sensitivity for detection of mixed Mycobacterium infections. Tuberculosis 2013;93:548-50
75. Post FA, Willcox PA, Mathema B et al. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis 2004;190:99-106
76. Reed MB, Gagneux S, DeRiemer K et al. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007;189:2583-9
77. Rhee JT, Tanaka MM, Behr MA et al. Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis. Int J Tuberc Lung D 2000;4:1111-9
78. Richardson M, Carroll NM, Engelke E et al. Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting. J Clin Microbiol 2002a;40: 2750-4
79. Richardson M, van Lill SW, van der Spuy GD et al. Historic and recent events contribute to the disease dynamics of Beijing-like Mycobacterium tuberculosis isolates in a high incidence region. Int J Tuberc Lung D 2002b; 6:1001-11
80. Rinder H. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J Med Microbiol 2001;50:1018-20
81. Romeyn JA. Exogenous reinfection in tuberculosis. Am Rev Respir Dis 1970;101:923-7
82. Shamputa IC, Jugheli L, Sadradze N et al. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia. Respir Res 2006;7:99
83. Shamputa IC, Rigouts L, Eyongeta LA et al. Genotypic and phenotypic heterogeneity among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients. J Clin Microbiol 2004;42:5528-36
84. Shamputa IC, Van Deun A, Salim MA et al. Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infection. Trop Med Int Health 2007;12:700-8
85. Shin SS, Modongo C, Ncube R et al. Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana. J Infect Dis 2014;211:347-51
86. Small PM, McClenny NB, Singh SP et al. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol 1993;31:1677-82
87. Sonnenberg P, Murray J, Glynn JR et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001;358:1687-93
88. Ssengooba W, Cobelens FG, Nakiyingi L et al. High genotypic discordance of concurrent Mycobacterium tuberculosis isolates from sputum and blood of HIV-infected individuals. PLoS One 2015;10:e0132581
89. Stavrum R, Mphahlele M, Øvreås K et al. High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. J Clin Microbiol 2009;47:1848-56
90. SteadWW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 1967;95:729-45
91. Streit E, Millet J, Rastogi N. Mycobacterium tuberculosis polyclonal infections and microevolution identified by MIRU-VNTRs in an epidemiological study. Int J Mycobacteriol 2015;4:222-7
92. Theisen A, Reichel C, Rüsch-Gerdes S et al. Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet 1995;345:1512-3
93. Umubyeyi AN, Shamputa IC, Rigouts L et al. Molecular investigation of recurrent tuberculosis in patients from Rwanda. Int J Tuberc Lung D 2007;11:860-7
94. van Embden JD, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9
95. van Rie A, Warren R, Richardson M et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. New Engl J Med 1999;341:1174-9
96. van Rie A, Victor TC, Richardson M et al. Reinfection and mixed infection cause changing Mycobacterium tuberculosis drugresistance patterns. Am J Respir Crit Care 2005;172:636-42
97. Verver S, Warren RM, Beyers N et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care 2005;171:1430-5
98. Verver S, Warren RM, Munch Z et al. Proportion of tuberculosis transmission that takes place in households in a highincidence area. Lancet 2004;363:212-4
99. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997;119:183-201
100. Wang JY, Hsu HL, Yu MC et al. Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain. Clin Microbiol Infect 2011;17:1239-45
101. Wang X, Liu H, Wei J et al. An investigation on the population structure of mixed infections of Mycobacterium tuberculosis in Inner Mongolia, China. Tuberculosis 2015;95:695-700
102. Warren RM, Victor TC, Streicher EM et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care 2004;169:610-4
103. WHO. Definitions and Reporting Framework for Tuberculosis-2013 revision. Geneva, Switzerland: WHO Press, World Health Organization, 2014
104. WHO. Global Tuberculosis Report. Geneva, Switzerland: WHO Press, World Health Organization, 2016a
105. WHO. Tuberculosis Country Profiles. 2016b, http://www.who.int/ tb/country/data/profiles/en/ (26 October 2016, date last accessed)
106. Yeh RW, Hopewell PC,Daley CL. Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int J Tuberc Lung D 1999;3:537-9
107. Zheng C, Li S, Luo Z et al. Mixed infections and rifampin heteroresistance among Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 2015;53:2138-47
108. Zumla A, Nahid P, Cole S. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Dis 2013;12:388-404